Market Place
Sourcing Support
OncoNano Medicine Presents ON-BOARD™ IL-12 Program Data at AACR
10 Apr 2024 //
BUSINESSWIRE
OncoNano Medicine to Present Late-Breaking Poster at AACR Meeting 2024
06 Mar 2024 //
BUSINESSWIRE
OncoNano Medicine Appoints Kartik Krishnan as Chief Executive Officer
01 Mar 2024 //
BUSINESSWIRE
OncoNano Announces First Patient Dosed in Phase 1 Study Evaluating ONM-501
27 Nov 2023 //
BUSINESSWIRE
OncoNano and Regeneron Enter into Trial Supply Agreement for Use of Libtayo
06 Sep 2023 //
BUSINESSWIRE
OncoNano Presents Positive Results from Phase 2 Trial of Pegsitacianine
31 May 2023 //
BUSINESSWIRE
OncoNano Medicine Announces Oral Presentation at the (ASCO) Annual Meeting 2023
27 Apr 2023 //
BUSINESSWIRE
OncoNano Medicine to Present at AACR Annual Meeting 2023
15 Mar 2023 //
BUSINESSWIRE
Pegsitacianine Granted Breakthrough Therapy Designation for Surgical Imaging
04 Jan 2023 //
BUSINESSWIRE
OncoNano Announces Pre-Clinical Data for Dual-Activating STING agonist at SITC
10 Nov 2022 //
BUSINESSWIRE
OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine
29 Sep 2022 //
BUSINESSWIRE
OncoNano Medicine to Present at Cantor Fitzgerald Oncology & HemOnc Conference
19 Sep 2022 //
BUSINESSWIRE
OncoNano Announces Presentation of PII Study Data at Congress 2022
14 Sep 2022 //
BUSINESSWIRE
OncoNano Medicine Appoints Kartik Krishnan, M.D., Ph.D., as CMO
01 Jun 2022 //
BUSINESSWIRE
OncoNano Appoints Elina Lavit as VP, Business Development
10 May 2022 //
BUSINESSWIRE
OncoNano Announces Positive PC Data for ONM-501 at AACR 2022 Annual Meeting
13 Apr 2022 //
BUSINESSWIRE
OncoNano Announces Positive Preclinical Data for Tumor Specific Delivery at AACR
12 Apr 2022 //
BUSINESSWIRE
OncoNano Medicine to Present at AACR 2022
10 Mar 2022 //
BUSINESSWIRE
OncoNano Announces $18.4 Million Equity Investment by the Cancer
25 Oct 2021 //
BUSINESSWIRE
OncoNano Med to Present at American Association for Cancer Research Conference
30 Sep 2021 //
BUSINESSWIRE
OncoNano Medicine Collaborates With UT Southwestern Medical Center for cancer
22 Sep 2021 //
BIOSPACE
OncoNano to Present at LifeSci Partners Private Company Summer Symposium
19 Jul 2021 //
BUSINESSWIRE
OncoNano Medicine Raises ~$50 Million in Series B Financing
18 Jun 2021 //
BUSINESSWIRE
OncoNano Medicine Raises ~$50 Million in Series B Financing
17 Jun 2021 //
BUSINESSWIRE
OncoNano Medicine Raises ~$50 Million in Series B Financing
16 Jun 2021 //
BUSINESSWIRE
OncoNano Announces Positive Preclinical Data for ONM-400 Tumor Specific IL-2
09 Nov 2020 //
BIOSPACE
OncoNano Announces Positive Preclinical Data for ONM-400 Tumor Specific IL-2
09 Nov 2020 //
BUSINESSWIRE
OncoNano Announces Positive Clinical Data for Cancer Imaging Agent ONM-100
07 Oct 2020 //
BUSINESSWIRE
OncoNano Awarded $9.97 Milli Grant from Cancer Prevention and Research Institute
20 Aug 2020 //
BUSINESSWIRE
OncoNano Awarded $9.97 M Grant from Cancer Prevention and Research Institute
19 Aug 2020 //
BUSINESSWIRE
